Moderna
MRNA
#1830
Rank
A$16.29 B
Marketcap
A$41.70
Share price
8.67%
Change (1 day)
-37.36%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Annual Reports (10-K)

Latest form 10-K annual reports for Moderna CIK: 0001682852

Thumbnail Moderna
 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)